What about the Ger­man ne­go­ti­a­tion mod­el? Biden steers drug pric­ing de­bate to a show­down

From an ill-fat­ed pro­pos­al to ban re­bates for phar­ma­cy ben­e­fit man­agers to an ex­ec­u­tive or­der de­mand­ing a “most-fa­vored-na­tion price” for Medicare, if noth­ing else Pres­i­dent Don­ald Trump has in­tro­duced Amer­i­cans to a flur­ry of ideas to rein in phar­ma, an in­dus­try he once ac­cused of “get­ting away with mur­der.” And now we’re get­ting the first glimpse of what a Joe Biden pres­i­den­cy might mean for pre­scrip­tion drug pric­ing.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER